Ticker Details
Forte Biosciences, Inc.
IPO Date:	April 10, 2017
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$363.78M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.56 | 4.17%
Avg Daily Range (30 D):	$1.60 | 5.34%
Avg Daily Range (90 D):	$1.22 | 5.49%

Institutional Daily Volume
Avg Daily Volume:	.06M
Avg Daily Volume (30 D):	.2M
Avg Daily Volume (90 D):	.15M

Trade Size
Avg Trade Size (Sh.):	39
Avg Trade Size (Sh.) (30 D):	62
Avg Trade Size (Sh.) (90 D):	61

Institutional Trades
Total Institutional Trades:	116
Avg Institutional Trade:	$1.67M
Avg Institutional Trade (30 D):	$1.64M
Avg Institutional Trade (90 D):	$1.59M
Avg Institutional Trade Volume:	.02M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.21M
Avg Closing Trade (30 D):	$.77M
Avg Closing Trade (90 D):	$1.14M
Avg Closing Volume:	20.99K

News

Aug 14, 2025 @ 5:00 PM Vitiligo Clinical Trial Pipeline Accelerates as 18... Source: Delveinsight

Jul 4, 2025 @ 10:00 AM Forte and Sequence Partner to Power Web3 Monetizat... Source: Bela Pandya (Forte Ceo)

Mar 25, 2024 @ 4:00 PM What Makes Forte Biosciences (FBRX) a New Buy Stoc... Source: Zacks Equity Research

Dec 13, 2023 @ 1:29 PM Research Frontiers And 3 Other Stocks Under $1 Ins... Source: Avi Kapoor

Dec 11, 2023 @ 1:34 PM RiskOn International And 3 Other Stocks Under $2 I... Source: Avi Kapoor

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$-.99	$-.96	$-1.37
Diluted EPS	$-.99	$-.96	$-1.37
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-17.68M	$-11.25M	$-15.66M
Operating Income / Loss	$-18.38M	$-11.58M	$-16.12M
Cost of Revenue
Net Cash Flow	$-12.73M	$60.29M	$23.61M
PE Ratio

Splits
Aug 28, 2024	1:25